Teva Pharmaceutical Industries Ltd (TEVJF) Return on Capital Employed (2009 - 2026)

Teva Pharmaceutical Industries' (TEVJF) quarterly Return on Capital Employed came in at 6.6% in Q2 2026, up 333.0% YoY from 1.52% in Q2 2025, and down 22.59% on a QoQ basis from 8.52% in Q1 2026.

Teva Pharmaceutical Industries Ltd (TEVJF) Return on Capital Employed (2009 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVJF) has 18 years of Return on Capital Employed data on file, last reported at 6.6% in Q2 2026.

  • Quarterly Return on Capital Employed rose 333.0% year-over-year to 6.6% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 6.6% (up 333.0% YoY) and the FY2025 annual result came in at 8.11%, up 917.0% from the prior year.
  • Return on Capital Employed fell to 6.6% in Q2 2026, from 8.52% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 8.52% in Q1 2026 to a low of 6.72% in Q4 2022.
  • A 5-year average of 0.92% and a median of 1.49% in 2023 frame the typical range for Return on Capital Employed.
  • The widest YoY moves for Return on Capital Employed: up 1042 bps in 2022, down 1140 bps in 2022.
  • Tracing TEVJF's Return on Capital Employed over 5 years: stood at 6.72% in 2022, then surged by 121 bps to 1.42% in 2023, then plunged by 177 bps to 1.09% in 2024, then soared by 835 bps to 8.03% in 2025, then decreased by 18 bps to 6.6% in 2026.
  • The last three Return on Capital Employed figures came in at 6.6% (Q2 2026), 8.52% (Q1 2026), and 8.03% (Q4 2025), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 6.60%
Mar 31, 2026 8.52%
Dec 31, 2025 8.03%
Sep 30, 2025 6.41%
Jun 30, 2025 3.26%
Mar 31, 2025 1.57%
Dec 31, 2024 -1.09%
Sep 30, 2024 1.74%
Jun 30, 2024 3.02%
Mar 31, 2024 0.78%
Dec 31, 2023 1.42%
Sep 30, 2023 -4.05%
Jun 30, 2023 -3.76%
Mar 31, 2023 -4.49%
Dec 31, 2022 -6.72%
Sep 30, 2022 -3.51%
Jun 30, 2022 -2.76%
Mar 31, 2022 1.59%
Dec 31, 2021 4.67%
Sep 30, 2021 5.57%